Clinical Trial Update: Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of annual and biennial zoledronic acid for osteoporosis in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: HIV Infections | Phase 4 | Status: COMPLETED